SOLARA.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 06:00):

Stats
Today's Volume	216 633
Average Volume	580 080
Market Cap	18.19B
EPS	INR0 ( 2024-02-14 )
Next earnings date	( INR0 ) 2024-05-09
Last Dividend	INR3.00 ( 2021-08-18 )
Next Dividend	INR0 ( N/A )
P/E	-5.90
ATR14	INR0.690 (0.14%)

Volume Correlation

Long: 0.19 (neutral)

Short: -0.99 (very strong negative)

Signal:(42.775) Neutral

Solara Active Pharma Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Solara Active Pharma Correlation - Currency/Commodity

-0.31
( neutral )

-0.38
( neutral )

-0.34
( neutral )

-0.43
( neutral )

-0.27
( neutral )

0.24
( neutral )

Solara Active Pharma Financials

Annual	2022
Revenue:	INR14.44B
Gross Profit:	INR6.55B (45.37 %)
EPS:	INR-6.16

FY	2022
Revenue:	INR14.44B
Gross Profit:	INR6.55B (45.37 %)
EPS:	INR-6.16

FY	2022
Revenue:	INR12.31B
Gross Profit:	INR5.33B (43.29 %)
EPS:	INR-16.22

FY	2021
Revenue:	INR16.17B
Gross Profit:	INR8.47B (52.40 %)
EPS:	INR69.00

Financial Reports:

No articles found.

Solara Active Pharma Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Solara Active Pharma Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.729 - No dividend growth expected in the near future

Information

First Dividend	INR5.00	2019-08-06
Last Dividend	INR3.00	2021-08-18
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR14.00	--
Avg. Dividend % Per Year	0.13%	--
Score	0.73	--
Div. Sustainability Score	0
Div.Growth Potential Score	1.729
Div. Directional Score	0.449	--

Next Divdend (Est)
(2024-12-02)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2019	INR5.00	1.62%
2020	INR6.00	1.41%
2021	INR3.00	0.25%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUNTV.NS	Dividend Knight	2023-08-22	Quarterly	19	1.94%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%
HPIL.NS	Dividend Junior	2023-09-29	Annually	5	0.89%
CARERATING.NS	Dividend Knight	2023-07-06	Semi-Annually	12	1.81%
ROSSELLIND.NS	No Dividend Player	2023-07-20	Sporadic	12	0.12%
LFIC.NS	Dividend Junior	2023-08-01	Annually	15	1.73%
GAEL.NS	Dividend Junior	2023-08-25	Annually	23	0.27%
APOLLOPIPE.NS	Dividend Junior	2023-09-15	Annually	3	0.07%
TCPLPACK.NS	Dividend Junior	2023-07-27	Annually	7	1.08%
OFSS.NS	Dividend Knight	2023-05-09	Annually	23	4.19%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.219	1.500	-4.38	-6.57	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.276	1.500	-4.18	-6.27	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-1.607	1.000	-1.706	-1.706	[3 - 30]
operatingCashFlowPerShareTTM	43.40	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	43.40	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.342	1.000	7.64	7.64	[0.2 - 0.8]
operatingProfitMarginTTM	-0.110	1.000	-4.20	-4.20	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.832

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-6.08	1.000	-0.715	0	[1 - 100]
returnOnEquityTTM	-0.276	2.50	-2.69	-6.27	[0.1 - 1.5]
freeCashFlowPerShareTTM	43.40	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	43.40	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.111	1.000	9.72	0	[0.1 - 0.5]
Total Score				1.729

Solara Active Pharma

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

Realtime updates for Solara Active Pharma [SOLARA.NS]

Upcoming Earnings Alert

Solara Active Pharma Dividend Information - No Dividend Player

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)